A Long-Term Study to Evaluate the Ability of Tenapanor Alone or in Combination With Sevelamer to Treat to Goal Serum Phosphorus in Patients With End-Stage Kidney Disease on Dialysis
Conditions:   Hyperphosphatemia;   End Stage Renal Disease Interventions:   Drug: Tenapanor;   Drug: Sevelamer Carbonate Sponsor:   Ardelyx Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2019 Category: Research Source Type: clinical trials

Individualized Treatment of Hyperphosphatemia in Maintenance Hemodialysis Patients
Conditions:   Maintenance Hemodialysis;   Hyperphosphatemia Interventions:   Drug: Phosphate-binder intervention;   Dietary Supplement: Phosphorus-restricted dietary intervention Sponsors:   Chen Jing;   Huadong Hospital;   Shanghai Tongji Hospital, Tongji University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2019 Category: Research Source Type: clinical trials